NASDAQ:IKNA
Ikena Oncology, Inc.
- Stock
Last Close
1.32
03/05 20:00
Market Cap
64.67M
Beta: 0.75
Volume Today
367.59K
Avg: 63.66K
PE Ratio
−0.98
PFCF: −0.87
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -16.82M - | -44.26M 163.16% | -34.12M 22.91% | -68.77M 101.57% | -68.17M 0.87% | |
depreciation and amortization | 243K - | 300K 23.46% | 544K 81.33% | 751K 38.05% | 1.02M 35.82% | |
deferred income tax | 2.87M - | |||||
stock based compensation | 1.17M - | 1.80M 53.72% | 5.18M 188.09% | 7.53M 45.35% | 7.63M 1.42% | |
change in working capital | 63.45M - | -7.77M 112.25% | -33.03M 325.07% | -15.14M 54.17% | -21.67M 43.14% | |
accounts receivables | -1.33M - | 519K 138.96% | 361K 30.44% | -291K 180.61% | -2.87M 886.25% | |
inventory | 1.33M - | -519K 138.96% | -361K 30.44% | 2.87M - | ||
accounts payables | -1.33M - | 519K 138.96% | 361K 30.44% | -291K 180.61% | -2.87M 886.25% | |
other working capital | 64.78M - | -8.29M 112.80% | -33.39M 302.81% | -14.56M 56.41% | -18.80M 29.15% | |
other non cash items | -121K - | 12.10M 10,103.31% | 1.17M 90.30% | 1.52M 29.30% | -1.43M 194.20% | |
net cash provided by operating activities | 47.93M - | -37.83M 178.92% | -60.25M 59.29% | -74.11M 23.00% | -79.74M 7.60% | |
investments in property plant and equipment | -316K - | -766K 142.41% | -1.76M 129.77% | -1.43M 18.69% | -414K 71.07% | |
acquisitions net | 3.69M - | 97.85M - | 40.03M 59.09% | |||
purchases of investments | -216.34M - | -90.05M 58.37% | ||||
sales maturities of investments | 118.48M - | 154.61M 30.49% | ||||
other investing activites | -97.85M - | -40.03M 59.09% | ||||
net cash used for investing activites | -316K - | 2.92M 1,024.68% | -1.76M 160.23% | -99.28M 5,541.14% | 64.14M 164.61% | |
debt repayment | ||||||
common stock issued | 16.32M - | 116.18M 612.09% | 131.30M 13.01% | 1.09M 99.17% | 37.56M 3,329.86% | |
common stock repurchased | -57K - | -146K 156.14% | -663K - | |||
dividends paid | ||||||
other financing activites | 1 - | 57K 5,699,900% | 582K 921.05% | 39.09M - | ||
net cash used provided by financing activities | 16.32M - | 116.18M 612.09% | 131.74M 13.39% | 1.09M 99.17% | 75.98M 6,838.81% | |
effect of forex changes on cash | -406K - | |||||
net change in cash | 63.93M - | 81.28M 27.15% | 69.73M 14.22% | -172.30M 347.11% | 59.98M 134.81% | |
cash at beginning of period | 18.16M - | 82.08M 352.10% | 163.36M 99.02% | 233.09M 42.68% | 59.92M 74.29% | |
cash at end of period | 82.08M - | 163.36M 99.02% | 233.09M 42.68% | 60.79M 73.92% | 119.89M 97.22% | |
operating cash flow | 47.93M - | -37.83M 178.92% | -60.25M 59.29% | -74.11M 23.00% | -79.74M 7.60% | |
capital expenditure | -316K - | -766K 142.41% | -1.76M 129.77% | -1.43M 18.69% | -414K 71.07% | |
free cash flow | 47.61M - | -38.59M 181.06% | -62.01M 60.69% | -75.54M 21.82% | -80.16M 6.11% |
All numbers in USD (except ratios and percentages)